As demand for complex biomarker analysis and precision oncology continues to grow, scaling multiplex immunofluorescence (mIF) and spatial biology into high-throughput production remains a major challenge. Fragmented workflows, manual processes, and complex image analysis pipelines often slow progress and require extensive bioinformatics expertise.

In this webinar, discover how ZEISS and Mindpeak are transforming spatial biology into a streamlined, production-ready workflow – delivering true “images in, results out” automation. Learn how the ZEISS AxioScan 7 Spatial Biology enables standardized, clinical-grade imaging of up to 100 slides per day, and how Mindpeak’s PhenoScout AI provides turnkey, expert-level single-cell analysis, no months of algorithm training required. Together, this fully integrated solution reduces data complexity, lowers operational overhead, and accelerates time-to-insight, creating a clear pathway from translational research and clinical trials to future diagnostic assays.

What We Will Cover

• High-Throughput Imaging: How the ZEISS AxioScan 7 enables standardized, clinical-grade imaging for up to 100 slides per day.
• Turn-key AI Analysis: How Mindpeak’s PhenoScout AI provides expert-grade, single-cell precision without requiring prior image analysis or algorithm training.
• Clinical Pathways: How this integration minimizes data handling, accelerates timeto-insight, and establishes a reliable path from research to future diagnostic assays.

Learning Objectives

• Identify key hurdles of bringing mIF/spatial biology into high-throughput production.
• Discuss solutions on the reagents, scanner, workflow, and image analysis parts of the workflow, with an emphasis on PhenoScout by Mindpeak.
• Evaluate the requirements for transitioning from manual research protocols to clinical-routine-ready imaging ecosystems.

Key Takeaways

• Spatial biology is now ready for production: Organizations can finally scale complex spatial workflows without sacrificing speed or reliability.
• Unlocking Massive Scale and Reliability (ZEISS Advantage): Achieve unprecedented throughput and standardization. By providing a highly reproducible, clinical-routine-ready imaging ecosystem, ZEISS allows labs to confidently process up to 100 slides per day, establishing a clear pathway from translational research to regulatory clearance.
• Eliminating the Analysis Bottleneck (Mindpeak Advantage): Experience “Zero Friction” spatial analysis. Mindpeak’s clinically validated AI completely removes the need for specialized bioinformatics expertise or months of software training. Users get immediate, expert-grade precision, freeing them to focus entirely on actionable biology rather than managing complex IT infrastructure.
• A Seamless, End-to-End Clinical Pathway: Together, ZEISS and Mindpeak deliver a fully automated, end-to-end solution. From standardized high-quality image acquisition to instant, reproducible biomarker reporting, the integrated workflow minimizes data handling complexities and accelerates time-to-insight for high throughput clients.
• Reduced Operational Overhead: Automation of both hardware and software steps significantly lowers the cost-per-slide and reduces human error, making spatial biology a viable option for large-scale clinical trials.
• Standardization for Future Diagnostics: This integrated approach provides the data consistency and quality control necessary to move biomarkers from the discovery phase toward validated clinical assays.

Speakers

• Dr. Moritz Widmaier, ZEISS
• Dr. Fabian Schneider, Senior Product Manager, Mindpeak